HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target
10/19/2026
Impact: 70
Healthcare
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on BrainsWay (NASDAQ: BWAY) and maintained a price target of $19 for the stock. This endorsement suggests confidence in the company's future performance.
AI summary, not financial advice
Share: